Columbia Laboratories Regains Compliance with Nasdaq Listing Standards

Before you go, we thought you'd like these...
Before you go close icon

Columbia Laboratories Regains Compliance with Nasdaq Listing Standards

BOSTON--(BUSINESS WIRE)-- Columbia Laboratories, Inc. (NasdaqCM:CBRX) received notice on August 23, 2012, from the Nasdaq Stock Market that the Company has regained compliance with the Nasdaq Stock Market minimum bid price requirement as set forth in Listing Rule 5550(a)(2). The notice stated that the closing bid price of the Company's common stock has been at $1.00 per share or greater for the previous ten consecutive business days.

About Columbia Laboratories


Columbia Laboratories, Inc. is a publicly traded specialty pharmaceutical company with a successful history of developing proprietary, vaginally administered products for women's health indications. For more information, please visit www.columbialabs.com.



Columbia Laboratories, Inc.
Jonathan Lloyd Jones, 617-639-1500
Vice President & CFO
or
The Trout Group LLC
Seth Lewis, 646-378-2952
Senior Vice President

KEYWORDS:   United States  North America  Massachusetts

INDUSTRY KEYWORDS:

The article Columbia Laboratories Regains Compliance with Nasdaq Listing Standards originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners